Live Quote · NASDAQTGTXHealthcare· Biotechnology

TG Therapeutics, Inc.

$53.31 0.39%($-0.21)
TickerSpark Score
86/100
Strong
57
Valuation
100
Profitability
100
Growth
72
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TGTX research report →

52-Week Range87% of range
Low
$25.28
Current
$53.31
High
$57.38
Company Overviewwww.tgtherapeutics.com

About the company

Based in New York City and established in 1993, TG Therapeutics, Inc. is a biopharmaceutical company that has advanced to the commercial stage. Its core mission revolves around the acquisition, advancement, and marketing of novel therapeutic solutions.

CEO
Michael S. Weiss
IPO
2010
Employees
352
HQ
Morrisville, NY, US

Price Chart

+46.90% · this period
$55.83$41.11$26.39Jul 02Dec 31Jul 02
Valuation
Market Cap
$8.16B
P/E
16.76
P/S
11.65
P/B
13.20
EV/EBITDA
56.41
Div Yield
0.00%
Profitability
Gross Margin
83.04%
Op Margin
21.35%
Net Margin
65.95%
ROE
87.36%
ROIC
11.13%
Growth & Income
Revenue
$616.29M · 87.32%
Net Income
$447.18M · 1812.41%
EPS
$3.10 · 1837.50%
Op Income
$123.32M
FCF YoY
38.40%
Performance & Tape
52W High
$57.38
52W Low
$25.28
50D MA
$43.23
200D MA
$34.65
Beta
1.60
Avg Volume
2.35M

Get TickerSpark's AI analysis on TGTX

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 11, 26Lonial Sagarother8,325
Jun 11, 26HUME DANIELother8,325
Jun 11, 26Hoberman Kennethother8,325
Jun 11, 26Echelard Yannother8,325
Jun 11, 26Charney Laurence Nother8,325
Jan 28, 26Charney Laurence Nother30,000
Jan 29, 26Charney Laurence Nother13,197
Jan 8, 26WEISS MICHAEL Sother622,000
Jan 8, 26Power Sean Aother90,000
Nov 24, 25Echelard Yannsell5,000
Coverage · TGTX

Our TGTX coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on TGTX yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate TGTX report →
Internal Compare

Similar companies

Peers in the same neighborhood.